Significance of Continuous Low-Dose Lenvatinib for the Treating of the Patients with Unresectable Thyroid Carcinoma

The tyrosine kinase inhibitor lenvatinib has been confirmed as an effective treatment option for patients with unresectable thyroid carcinoma. We conducted a retrospective analysis of the significance of the effect of continued lenvatinib treatment for the longest duration possible at a reasonable d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta medica Okayama 2024-02, Vol.78 (1), p.63-70
Hauptverfasser:	Murakami, Daizo, Nishimoto, Kohei, Takao, Soshi, Miyamaru, Satoru, Kadowaki, Tomoka, Saito, Haruki, Takeda, Hiroki, Ise, Momoko, Suyama, Koichi, Orita, Yorihisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Carcinoma Humans Phenylurea Compounds - therapeutic use Quinolines Retrospective Studies Thyroid Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!